OpenCitations
Works that cite this article, indexed by OpenCitations.
Botulinum toxin in management of back pain
Quality in Sport 15 (2024)
Blanka Łuczak; Bianka Nowińska; Katarzyna Słychan; Izabela Hądzlik; Jan Piotrowski; Julia Biały-Karbowniczek; Klaudia Bulska; Patrycja Brzozowska; Andrzej Piela; Konrad Sławek
Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain
Toxins 8(12) (2016)
Duarte Machado; Aditya Kumar; Bahman Jabbari
Are paraspinous intramuscular injections of botulinum toxin a (BoNT-A) efficient in the treatment of chronic low-back pain? A randomised, double-blinded crossover trial
BMC Musculoskeletal Disorders 18(1) (2017)
Mélanie Cogné; Hervé Petit; Alexandre Creuzé; Dominique Liguoro; Mathieu de Seze
Botulinum toxin type A for treating chronic low back pain: A double blinded randomized control study
World Journal of Methodology 14(3) (2024)
Mantu Jain; Shahnawaz Khan; Paulson Varghese; Sujit Kumar Tripathy; Manaswini Mangaraj
Botulinum Neurotoxins and Chronic Low Back Pain
Botulinum Toxin Treatment of Pain Disorders (2022)
Bahman Jabbari
Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis
BMJ (2021)
Aidan G Cashin; Thiago Folly; Matthew K Bagg; Michael A Wewege; Matthew D Jones; Michael C Ferraro; Hayley B Leake; Rodrigo R N Rizzo; Siobhan M Schabrun; Sylvia M Gustin; Richard Day; Christopher M Williams; James H McAuley
Injection Botulinum Toxin A in Treatment of Resistant Chronic Low Back Pain: A Prospective Open-Label Study
Cureus (2021)
Jagannatha Sahoo; Debasish Jena; Amrutha Viswanath; Apurba Barman